Bristol-Myers Squibb offers floaters, six series of fixed-rate notes

By Marisa Wong

Los Angeles, Nov. 9 – Bristol-Myers Squibb Co. plans to price a single tranche of floating-rate senior notes and also fixed-rate senior notes in six parts, according to a 424B3 filing with the Securities and Exchange Commission.

Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Barclays and Deutsche Bank Securities Inc. are the joint bookrunners.

Proceeds will be used to help finance Bristol-Myers Squibb’s acquisition of MyoKardia, Inc. and for general corporate purposes.

The biopharmaceutical company is based in New York.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.